An excerpt of non‑cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management (2024)

Junqi XIA, Zhe LYU, Chenghai LIU, Xingshun QI

PDF(481 KB)
PDF(481 KB)
Journal of Clinical Hepatol ›› 2025, Vol. 41 ›› Issue (1) : 41-43. DOI: 10.12449/JCH250106
Guideline

An excerpt of non‑cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management (2024)

Author information +
History +

Abstract

Recently, Asian Pacific Association for the Study of the Liver published the recommendations for the diagnosis and management of non-cirrhotic portal fibrosis (NCPF)/idiopathic portal hypertension (IPH). The guidelines mainly elaborate on the definition, diagnosis, histological features, natural history, and management of NCPF/IPH, in order to strengthen the understanding of NCPF/IPH-related issues and establish a global consensus. This article makes an excerpt of the key statements in the guidelines.

Key words

Liver Diseases / Fibrosis / Hypertension, Portal / Practice Guidelines

Cite this article

Download Citations
Junqi XIA , Zhe LYU , Chenghai LIU , et al. An excerpt of non‑cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management (2024). Journal of Clinical Hepatol. 2025, 41(1): 41-43 https://doi.org/10.12449/JCH250106

References

1
SHUKLA A, ROCKEY DC, KAMATH PS, et al. Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management[J]. Hepatol Int, 2024, 18(6): 1684-1711. DOI: 10.1007/s12072-024-10739-6 .

夏俊琪、吕哲负责翻译,对本文贡献等同,为共同第一作者;刘成海、祁兴顺负责审校。

Funding

National Key R & D Program of China(2023YFC2507500)
Outstanding Youth Foundation of Liaoning Province(2022-YQ-07)
Applied Basic Research Program of Liaoning Province (Joint Program)(2022JH2/101500032)

Comments

PDF(481 KB)

Accesses

Citation

Detail

Sections
Recommended

/